Etiopathology of Behçet's Disease: Immunological Aspects

Yonsei Medical Journal

Volumn 38, Issue 6, 1997, Pages 350-358

  Sakane, Tsuyoshi ^a   Suzuki, Noboru ^a   Nagafuchi, Hiroko ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Heat shock protein (hsp); HLA B51; Neutrophil; TNF

Indexed keywords

CHAPERONIN;

BEHCET DISEASE; EYE; HUMAN; IMMUNOLOGY; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; REVIEW; SKIN; T LYMPHOCYTE;

BEHCET SYNDROME; CHAPERONIN 60; EYE; HUMANS; NEUTROPHILS; SKIN; T-LYMPHOCYTES;

EID: 0031304383     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1997.38.6.350     Document Type: Article

References (53)

1. Arbesfeld SJ, Kurban AK: Behçet's disease. J Am Acad Dermatol 19: 767-779, 1988
2. Aydintug AO, Tokgoz G, Ozoran K, Dozgun N, Gurler A, Tutkak H: Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int 15: 75-78, 1995
3. Burrows NP, Zhao MH, Norris PG, Lockwood CM: ANCA associated with Behçet's disease. J R Soc Med 89: 47-48, 1996
4. Chajek-Shaul T, Pisanty S, Knobler H, Matzner Y, Glick M, Ron N, Rosenman E, Brautbar C: HLA-B51 may serve as an immunogenetic marker for subgroup of patients with Behçet's syndrome. Am J Med 83: 666-672, 1987
5. Charteris DG, Barton K, McCartney ACE, Lightman SL: CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity 12: 201-206, 1992
6. Charteris DG, Champ C, Rosenthal AR, Lightman SL: Behçet's disease: activated T lymphocytes in retinal perivasculitis. Br J Opthalmol 76: 499-501, 1992.
7. de Jesus H, Marques A, Romeu JC, Rosa M, da Costa M, Oueiroz V: Association of Behçet's disease and antiphospholipid syndrome. A report of 3 cases. Reveu du Rheumatisme(July-September): 544, 1996
8. Direskeneli H, Hanan A, Shinnick T, Mizushima R, van der Zee R, Fortune F, Stanford MR, Lehner T: Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol 43: 464-471, 1996
9. Direskeneli H, Keser G, D'Cruz D, Khamashta MA, Akoglu T, Yazici H, Yurdakul S, Hamuryudan V, Ozgun S, Goral AJ : Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol 14: 55-61, 1995
10. Eksioglu-Demiralp E, Maptas C, Direskeneli H, Ergun T, Hamuryudan V, Akoglu T: Serum transforming growth factor-β (TGF-β) level in Behçet's disease. Reveu du Rheumatisme(July-September): 529, 1996
11. Erken E, Gunesacar R, Soylu M: Correlation between IL-8 and soluble GMP-140 levels in Behçet's disease. Reveu du Rheumatisme(July-September): 529, 1996
12. Esin S, Gul A, Hodara V, Jeddi-Tehrani M, Dilsen N, Konice M, Andersson R, Wigzell H: Peripheral blood T cell expansions in patients with Behçet's disease, Clin Exp Immunol 107: 520-527, 1997
13. Feron EJ, Calder VL, Lightman SL: Distribution of IL-2R and CD45Ro expression on CD4+ and CD8+ T-lymphocytes in the peripheral blood of patients with posterior uveitis. Curr Eye Res 11: 167-172, 1992
14. Fortune F, Walker J, Lehner T: The expression of γδ T cell receptor and prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome. Clin Exp Immunol 82: 326-332, 1990
15. Fye KH, Sack KE: Behçet's disease. In Stites DP, Stobo JD, Fudenberg HH, Wells JV, eds. Basic and clinical immunology. Los Altos, Lange Medical Publications, 1982, 453-454
16. Guermazi S, Hamza M, Dellagi K: Protein S deficiency and antibodies to protein S in patients with Behçet's disease. Thromb Res 86: 197-204, 1997
17. Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P: Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol 132: 901-907, 1995
18. Gupta RC, O'Duffy JD, McDuffie FC, Meurer M, Jordan RE: Circulating immune complexes in active Behçet's disease. Clin Exp Immunol 34: 213-218, 1978
19. Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M: Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J Rheumatol 21: 2301-2306, 1994
20. Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, van der Zee R, Stanford MR, Sanderson J, Lehner T: Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 347: 789-794, 1996
21. Hayasaka S, Hara S, Mizuno K: Lysosomal enzymes in the serum of patients with Behçet's disease. Albrecht Von Graefes. Arch Klin Exp Ophthalmol 203: 139-144, 1977
22. Inaba G, Kaku H, Ujihara H, Miyanaga Y, Hara R: Leukocyte adhesion molecules in active ocular lesions in Behçet's disease. In Wechsler B, Godeau P, eds. Behçet's disease. Excerpta Medica, 1993, 13-18
23. Inoue C, Itoh R, Kawa Y, Mizoguchi M: Pathogenesis of mucocutaneous lesions in Behçet's disease. J Dermatol 21: 474-480, 1994
24. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, Yamamoto S, Sakane T: Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108: 204-212, 1997
25. Kaneoka H, Furukawa H, Takeno M, Mizushima Y, Sakane T: HLA-B51 involved in the hyperfunction of peripheral blood neutrophil from patients with Behçet's disease. In Wechsler B, Godeau P, eds. Behçet's disease. Excerpta Medica, 1993, 29-32
26. Kansu E, Sahin G, Sahin F, Siviri B, Sayek L, Batman F: Impaired procyclin synthesis by vessel walls in Behçet's disease. Lancet 15: 1154, 1986
27. Korn S, DeHoratius RJ: Immunology: humoral immunity. In: Plotkin G R, Calabro J J, O'Duffy J D, eds. Behçet's disease: a contemporary synopsis. Mount Kisco, Furta, 1988, 29-50
28. Lehner T: Recent advances in cellular and humoral immunity in Behçet's syndrome. In Inaba G, ed. Behçet's disease: pathogenetic mechanism and clinical future. Tokyo, University of Tokyo Press, 1982, 357-368
29. Lehner T, Lavery E, Smith R, van der Zee R, Mizushima Y, Shinnick T: Association between the 65-kilodalton heat shock protein, Streptococcus sangius, and the corresponding antibodies in Behçet's syndrome. Infect Immunol 59: 1434-1441, 1991
30. Matzner Y, Leibovici V: Increased neutrophil chemotaxis. A secondary phenomenon useful in the diagnosis and follow up of diseases with inflammatory component. Acta Paediatr Hung 29: 191-195, 1988
31. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C: Overproduction of monocyte derived tumor necrosis factor α, interleukin(IL) 6, IL-8 and increased neutrophil Superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20: 1544-1549, 1993
32. Navarro M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G, Lopez-Soto A, Ordinas A, Ingelmo M: Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6: 521-526, 1997
33. Nishikawa M, Furukawa H, Kaneoka, Miki T, Aikawa E, Sakane T: Autocrine cytokine-production of neutrophils in Behçet's disease. Annual Report of Behçet's Disease Research Commitee of Japan. Tokyo, Ministry of Health and Welfare of Japan, 1993, 208
34. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M: Auto-oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49: 247-255, 1982
35. Ozoran K, Dugun N, Gurler A, Tutkak H, Tokgoz G: Plasma von Willebrand factor, tissue 'plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 24: 376-382, 1995
36. Parronchi P, Sampognaro S, Marchione T, Brugnolo F, LiGobbi F, Emmi L, Maggi E, Romagnani S: Phenotypic and functional characterization of T-cell clones derived from cerebrospinal fluid in neuro-Behçet. Revue du Rheumatism (July-September): 552, 1996
37. Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, Vaughan R, Lehner T: T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease, J Immunol 151: 2273-2282, 1993
38. Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R: Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55: 128-133, 1996
39. Sakane T, Kotani H, Takada S, Tsunematsu T: Functional aberration of T cell subsets in patients with Behçet's disease. Arthritis Rheum 25: 1343-1351, 1982
40. Sakane T, Kotani H, Ueda Y, Takada S, Murakawa Y, Hoshino T, Niwa Y, Tsunematsu T:Analysis of interleukin-2 activity in patients with Behçet's disease: ability of T cells to produce and respond to interleukin-2. Arthritis Rheum 29: 371-378, 1986
41. Sasada M, Asagoe K, Shibata E, Hara Y, Yuasa T: Interaction between platelets and neutrophils in the pathogenesis of Behçet's disease: The effect of platelets and their products on the intracellular free calcium concentration of neutrophil. Annual Report of Behçet's Disease Research Committee of Japan. Tokyo, Ministry of Health and Welfare of Japan, 1994, 200
42. Sensi A, Gavioli R, Spisani S, Balboni A, Melchiorri L, Menicucci A, Palumbo G, Traniello S, Baricordi OR: HLA B51 antigen associated with neutrophil hyper-reactivity. Dis Markers 9: 327-331, 1991
43. Stanford MR, Kasp E, Whiston R, Hasan A, Todryk S, Shinnick T, Mizushima Y, Dumound DC, van der Zee R, Lehner T: Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol 97: 226-231, 1994
44. Suzuki N, Sakane T, Ueda Y, Tsunemastu T: Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum 29: 212-219, 1986
45. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y: Increased peripheral blood γδ+ T cells and natural killer cells in Behçet's disease. J Rheumatol 19: 588-592, 1992
46. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 38: 426-433, 1995
47. Tokay S, Direskeneli H, Yurdakul S, Akoqlu T: IgA anticardiolipin antibodies in Behçet's disease. Reveu du Rheumatisme(July-September): 544, 1996
48. Treudler R, Ketteler R, Orfanos CE, Zouboulis ChC: Increased serum levels of interleukin (IL) 1-beta and basic fibroblast growth factor (bFGF) in severe Adamatiades Behçet's disease. Reveu. du Rheumatisme (July-September): 529, 1996
49. Ural AU, Yalcin A, Beyan C, Isimer A, Bayhan H: Plasma endothelin-1 concentrations in patients with Behçet's disease. Scand J Rheumatol 23: 322-325, 1994
50. Uslu T, Erem C, Tosun M, Deger O: Plasma endothelin-1 levels in Behçet's disease. Clin Rheumatol 16: 59-61, 1997
51. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T: Role of γδ T lymphocytes in the development of Behçet's disease. Clin Exp Immunol 107: 241-247, 1997
52. Yamashita N, Nagafuchi H, Ueda Y, Mizoguchi M, Sakane T: Cytokine profiles and expression of heat shock protein (hsp) 60 in skin biopsy specimens in patients with Behçet's disease. Annual Report of Behçet's Disease Research Committee of Japan. Tokyo, Ministry of Health and Welfare of Japan, 1996, 208
53. Yoshizaki K, Aoki C, Nishimoto N, Shima Y, Kishimoto T: Serum levels of TNF-α and IL-6 in Behçet's disease. Annual Report of Behçet's Disease Research Committee of Japan. Tokyo, Ministry of Health and Welfare of Japan, 1995, 208